Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
Authors
Keywords
-
Journal
Science Immunology
Volume 5, Issue 49, Pages eabc2728
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-07-18
DOI
10.1126/sciimmunol.abc2728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
- (2020) Anthony R. Cillo et al. IMMUNITY
- Fast interpolation-based t-SNE for improved visualization of single-cell RNA-seq data
- (2019) George C. Linderman et al. NATURE METHODS
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
- (2019) Lawrence P. Andrews et al. NATURE IMMUNOLOGY
- The IFITM protein family in adaptive immunity
- (2019) Diana C. Yánez et al. IMMUNOLOGY
- Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments
- (2018) Stefan F Lichtenthaler et al. EMBO JOURNAL
- Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma
- (2018) J.M. Moskovitz et al. JOURNAL OF DENTAL RESEARCH
- Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors
- (2018) Laleh Haghverdi et al. NATURE BIOTECHNOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
- (2018) Robert L. Ferris et al. ORAL ONCOLOGY
- IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammation
- (2018) Diana C. Yánez et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Massively parallel digital transcriptional profiling of single cells
- (2017) Grace X. Y. Zheng et al. Nature Communications
- Essential Roles of SATB1 in Specifying T Lymphocyte Subsets
- (2017) Kiyokazu Kakugawa et al. Cell Reports
- PKCθ links proximal T cell and Notch signaling through localized regulation of the actin cytoskeleton
- (2017) Graham J Britton et al. eLife
- Distinct requirement of Runx complexes for TCRβ enhancer activation at distinct developmental stages
- (2017) Wooseok Seo et al. Scientific Reports
- Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2016) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- KLRG1 restricts memory T cell antitumor immunity
- (2016) Lei Li et al. Oncotarget
- LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
- (2016) Wei-Wei Deng et al. OncoImmunology
- Inhibitory receptors as targets for cancer immunotherapy
- (2015) Meghan E. Turnis et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Distinct TCR signaling pathways drive proliferation and cytokine production in T cells
- (2013) Clifford S Guy et al. NATURE IMMUNOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Camera: a competitive gene set test accounting for inter-gene correlation
- (2012) Di Wu et al. NUCLEIC ACIDS RESEARCH
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
- (2010) R. Bos et al. CANCER RESEARCH
- Stability of the Regulatory T Cell Lineage in Vivo
- (2010) Y. P. Rubtsov et al. SCIENCE
- LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis
- (2009) C. J. Workman et al. JOURNAL OF IMMUNOLOGY
- Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
- (2009) Lorraine A. O’ Reilly et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now